News


All News

Pediatric atopic dermatitis and acne have some similarities when these present in skin of color and lighter-skin children. But there are important differences when these common skin conditions affect darker skin types. An expert discusses how treatments should be approached.

Can costs be contained?

There’s a lot of blame to go around when it comes to why drug costs are rising in dermatology. We’ll let the research do the finger pointing.

Laser fundamentals

A review of basic laser knowledge will help dermatologists improve operating room and patient safety as well as ensure optimal outcomes. One expert offers tips for assessing space, equipment and patients.

The options for tattoo removal are more numerous and more effective than ever. Picosecond technology, quad treatments, Perfluorodecalin, macrophage targeting, and Q-switched lasers allow people with ink regret more effective ways to return their skin to pre-tat status.

Research has demonstrated that staph aureus is in increased supply on the skin of atopic dermatitis patients coupled with less overall diversity in the number of bacteria on their skin, suggesting therapies that achieve balance in the skin microbiome could help to manage atopic dermatitis.

Dermatologists, once considered generally immune to burnout, are seeing a sharp increase in occupational fatigue and we're offering some ideas for this Labor Day Weekend to help regain that strong work-life balance.

Corporations wish to grow and get bigger until finances intervene and then sometimes split or spin off children in the form of smaller corporations. Now corporations have overtaken medicine. What does this mean for the physician?

Is there a skinny gene?

It has been often wondered why some people tend to be heavier than others and if a specific gene plays a role.

As Zika spreads and proliferates in the U.S., dermatologists need to familiarize themselves with population risk factors and techniques to diagnose and treat this disease

Researchers examining Medicare prescribing patterns of oral anticoagulants and non-insulin diabetes drugs have found that pharmaceutical marketing to physicians involving payments was associated with physicians being more likely to prescribe those marketed drugs.

With the recent discoveries of immunologic pathways leading to psoriasis, clinicians are likely to discount older general immunosuppressive agents in favor of newer larger molecules like biologics that provide better targeted therapy.

Many dermatologists are approached by parties interested in acquiring a practice. Knowing ahead of time what questions you should ask-and how to answer their questions-can turn a simple inquiry by them into a wealth of information for you.

The costs of popular drugs-even generics-in dermatology are soaring, leaving patients scrambling for coverage or financial assistance and dermatologists spending precious hours on prior authorizations, drug appeals and reviews. In this first of a five-part series, experts and patients help define the problem.